BTAI - Latest News
BioXcel Therapeutics, Inc. (BTAI), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $5.6M. Beta to the broader market is 0.29.
The article list below shows the most recent BTAI headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BTAI Headlines
BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
globenewswire.com - Aug 28, 2026
BioXcel Therapeutics intends to complete a court-supervised sale transaction, in an effort to maximize value for all stakeholders Teva Pharmaceuticals
Biopharma firm BioXcel Therapeutics files for bankruptcy in US
reuters.com - Aug 27, 2026
AI-driven biopharma firm BioXcel Therapeutics filed for Chapter 11 bankruptcy protection in the U. S.
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Misses Revenue Estimates
zacks.com - Aug 13, 2026
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Given Average Recommendation of “Hold” by Brokerages
defenseworld.net - Aug 3, 2026
Shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI - Get Free Report) have received an average recommendation of "Hold" from the four ratings firms t
What Makes BioXcel Therapeutics (BTAI) a New Buy Stock
zacks.com - Jun 2, 2026
BioXcel Therapeutics (BTAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This migh
How News Affects BTAI Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BTAI's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BTAI news questions
- What is the latest BTAI news headline?
- The most recent BTAI headline (Aug 28, 2026) is "BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BTAI news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BTAI news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BTAI options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.